We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Drug Discovery

Stay up to date on the topics that matter to you

Contrasting LBAs and LC-MS for Peptide and Protein Bioanalysis

Video

Published: May 4, 2018

Kelly Doering discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS. She'll then present three examples of when LC-MS is the preferred method for quantification of insulin analogs based on specificity requirements and the need to multiplex.